•
Shanghai-based surgical robotics specialist, Ronovo Surgical, has reportedly raised over RMB 300 million (USD 41.3 million) in a Series B financing round. The funding round was co-led by Guolian Group and Ince Capital, with contributions from King Star Med LP and existing investor LongRiver. The capital will be utilized to…
•
Shanghai-based minimally invasive surgical robot developer, Ronovo Surgical, has reportedly raised close to RMB 200 million (USD 27.5 million) in a pre-Series B+ financing round. The round was led by NRL Capital, with contributions from Kington Capital, Lilly Asia Ventures, Vivo Capital, Matrix Partners, GGV Capital, and LongRiver Investments. The…